This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Determination of the Prevalence of Postcovid Syndrome and Assessment of the Effectiveness of the Drug Cortexin in the Treatment of Neurological Disorders in Patients with Postcovid Syndrome. Results of the CORTEX Multicenter Clinical and Epidemiological Observational Program.
Neuroscience and behavioral physiology, 52(6), 836-841
Citation
Putilina, M V; Mutovina, Z Yu; Kurushina, O V; Khalilova, D M; Saverskaya, E N; Stepanova, S B; Khoreva, M A; Starikov, A S. (2022). Determination of the Prevalence of Postcovid Syndrome and Assessment of the Effectiveness of the Drug Cortexin in the Treatment of Neurological Disorders in Patients with Postcovid Syndrome. Results of the CORTEX Multicenter Clinical and Epidemiological Observational Program.. Neuroscience and behavioral physiology, 52(6), 836-841. https://doi.org/10.1007/s11055-022-01307-2